Search results
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 2 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
Post-Traumatic Stress Disorder (PTSD)
Health via Yahoo News· 5 days agoDiagnosis If you or a loved one are experiencing symptoms of post-traumatic stress disorder, seeing ...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WUSF 89.7· 20 minutes agoA panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for ...
Service dogs helped ease PTSD symptoms in US military veterans, researchers say
seattlepi.com· 2 hours agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
Get Healthy Carson City: Post-traumatic stress disorder awareness
Nevada Appeal· 2 days agoPost-traumatic stress disorder (PTSD) develops in some people who have experienced a shocking,...
Placebos can ease certain mental disorders, study finds
WKBT La Crosse· 6 days agoSymptoms of nine mental health disorders substantially improved under placebo treatment, according...
One Senior Place: PTSD can affect seniors who have health issues, have lost loved ones
Florida Today via Yahoo News· 15 hours agoQ: Can PTSD affect seniors? A: Post-Traumatic Stress Disorder (PTSD) has thankfully lost its stigma...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 9 minutes agoLykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire SAN JOSE, Calif., June 4, 2024 SAN JOSE, Calif., June 4, 2024 /PRNewswire/ -- Lykos Therapeutics ("Lykos"), a company
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via AOL· 59 minutes agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
Flawed, scandalous trials tank FDA expert support for MDMA therapy
Ars Technica· 44 minutes agoIn response to the second question, "Do the benefits of midomafetamine with FDA’s proposed risk...